Remarkably, the therapeutic shortcoming of the γ-secretase in AD-iNSC also degenerated the mitophagy and mitochondrial impairments, similarly to the impact of the PS1/PS2 double knockout-iNSC [21]. Here, PSEN1 is linked to Alzheimer disease.